MAPS Phase 2 Study Published
KRF is Pleased to Announce the Publication of our MAPS Phase 2 Study of Anxiety and Life Threatening Illness by Wolfson et al and Phil’s accompanying Commentary on PTSD and Life Threatening illnesses.
Questions? Call us (415) 785-3797
KRF is Pleased to Announce the Publication of our MAPS Phase 2 Study of Anxiety and Life Threatening Illness by Wolfson et al and Phil’s accompanying Commentary on PTSD and Life Threatening illnesses.
Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy
Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy